• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    3M Annual Meeting Highlights Progress on Strategic Priorities, Improving Execution

    5/14/24 4:17:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email

    ST. PAUL, Minn., May 14, 2024 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) highlighted its strong portfolio of leading businesses, leading innovation in material science, and progress in executing the company's strategic priorities.

    "In 2023, we took significant action to improve our performance across our businesses and our operational execution. Our results demonstrate the positive impact of the changes we have made over the last several years, " said 3M executive chairman Mike Roman. "The progress we have made in executing our strategic priorities positions the company for long-term shareholder value creation as Bill Brown assumes the role of 3M CEO."

    Preliminary Shareholder Voting Results

    3M shareholders today voted on four business items:

    1)  Shareholders elected 12 directors for one-year terms that expire at the company's 2025 Annual Meeting:

    • Thomas "Tony" K. Brown, retired group vice president, Global Purchasing, Ford Motor Company
    • William M. "Bill" Brown, chief executive officer, 3M Company
    • Audrey Choi, retired chief sustainability officer and chief marketing officer, Morgan Stanley
    • Anne H. Chow, retired chief executive officer, AT&T Business
    • David B. Dillon, retired chairman of the board and chief executive officer, The Kroger Co.
    • James R. Fitterling, chairman of the board and chief executive officer, Dow Inc.
    • Amy E. Hood, executive vice president and chief financial officer, Microsoft Corporation
    • Suzan Kereere, president, global markets, PayPal
    • Gregory R. Page, retired chairman of the board and chief executive officer, Cargill
    • Pedro J. Pizarro, president and chief executive officer and director, Edison International
    • Michael F. Roman, executive chairman and former chief executive officer, 3M Company
    • Thomas W. Sweet, retired chief financial officer, Dell Technologies

    2)  Shareholders ratified the appointment of PricewaterhouseCoopers LLP as 3M's independent registered public accounting firm for 2024.

    3)  Approval, on an advisory basis, of executives' compensation as described in the proxy statement did not receive the requisite number of favorable votes.

    4)  Shareholders did not approve a shareholder proposal on an enhanced share ownership policy.

    3M will disclose the final voting results on each item of business properly presented at the Annual Meeting on Form 8-K to be filed with the SEC.

    With respect to the proposal to approve, on an advisory basis, the Company's executive compensation as described in the proxy statement, the Board of Directors takes the results of the annual advisory vote seriously. The Compensation and Talent Committee of the Board reviews our executive compensation program on an annual basis and considers shareholder perspectives as one of the critical inputs in this review process. The Company looks forward to engaging in further dialogue with its shareholders to understand their views while working to ensure alignment of the executive compensation program with the interests of our shareholders.

    Forward-Looking Statements

    This news release contains forward-looking statements. You can identify these statements by the use of words such as "plan," "expect," "aim," "believe," "project," "target," "anticipate," "intend," "estimate," "will," "should," "could," "would," "forecast" and other words and terms of similar meaning. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation, recession, military conflicts, and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals; known as "PFAS," including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company's plans to exit PFAS manufacturing and discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement to resolve claims by public water systems in the United States regarding PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q and 8-K (the "Reports"); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the spin-off of the Company's Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential business disruption; the diversion of management time; the impact of the transaction on the Company's ability to retain talent; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; the risk that any consents or approvals required will not be obtained; risks under the agreements and obligations entered into in connection with the spin-off, and (16) matters relating to Combat Arms Earplugs ("CAE"), including those related to, the August 2023 settlement that is intended to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Company's subsidiary Aearo Technologies and certain of its affiliates and/or the Company. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

    About 3M

    3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news.

    Please note that the company announces material financial, business and operational information using the 3M investor relations website, SEC filings, press releases, public conference calls and webcasts. The company also uses the 3M News Center and social media to communicate with our customers and the public about the company, products and services and other matters. It is possible that the information 3M posts on the News Center and social media could be deemed to be material information. Therefore, the company encourages investors, the media and others interested in 3M to review the information posted on 3M's news center and the social media channels such as @3M or @3MNews.

    Contacts



    Investor Contacts: 

    Bruce Jermeland, 651-733-1807 

    or 

    Diane Farrow, 612-202-2449 

    or

    Eric Herron, 651-233-0043



    Media contact: 

    Sean Lynch, slynch2@mmm.com

    3M (PRNewsfoto/3M)

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/3m-annual-meeting-highlights-progress-on-strategic-priorities-improving-execution-302145422.html

    SOURCE 3M Company

    Get the next $MMM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    7/17/2026$180.00Neutral → Overweight
    Analyst
    6/15/2026$190.00Buy
    Goldman
    6/10/2026$131.00Underperform
    Bernstein
    1/16/2026$182.00Overweight → Neutral
    Analyst
    12/8/2025$178.00Buy → Hold
    Deutsche Bank
    10/22/2025$160.00Underweight → Equal-Weight
    Morgan Stanley
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    More analyst ratings

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

    For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

    1/22/21 3:54:10 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    3M Reports Second-Quarter 2026 Results; Increases Full-Year Guidance

    Q2 GAAP sales of $6.5 billion, up 2.4%; operating margin of 15.1%, down 290 bps; EPS of $1.78, up 33%, all YoY Adjusted sales of $6.5 billion with organic growth of 5.4% YoYAdjusted operating margin of 24.9%, up 40 bps YoYAdjusted EPS of $2.40, up 11% YoYQ2 operating cash flow of $1.0 billion with adjusted free cash flow of $1.3 billion2026 adjusted EPS guidance increased from $8.50 - $8.70 to $8.80 - $8.95ST. PAUL, Minn., July 21, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today reported second-quarter results."We delivered a strong second quarter, exceeding expectations with mid-single-digit sales growth, robust operating margins of about 25%, and double-digit EPS growth, reflecting the progress w

    7/21/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M and Microsoft announce strategic partnership to advance AI data center infrastructure and enterprise transformation

    Microsoft becomes first announced hyperscale cloud provider to deploy 3M Expanded Beam Optical (EBO) technology 3M to use Microsoft AI and digital capabilities to advance enterprise transformation across key functions ST. PAUL, Minn. and REDMOND, Wash., July 15, 2026 /PRNewswire/ -- 3M (NYSE:MMM) and Microsoft (NASDAQ:MSFT) today announced a strategic partnership focused on AI data center infrastructure and enterprise transformation. Microsoft's Azure Cloud and AI Infrastructure will become the first announced hyperscale cloud provider to deploy 3M's Expanded Beam Optical (EBO) technology. 3M will also use Microsoft's AI and digital platforms as part of its enterprise transformation across k

    7/15/26 9:01:00 AM ET
    $MMM
    $MSFT
    Medical/Dental Instruments
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Scotch™ Brand launches Scotch Kids® Tape for young creators

    New kid-friendly collection supports hands-on creativity, crafting and building for children ages four and upST. PAUL, Minn., July 14, 2026 /PRNewswire/ -- Scotch™ Brand has launched Scotch® Kids Tape to help children create, craft and share their creativity. Designed for kids ages four and up, Scotch® Kids Tape supports crafting, decorating and building projects for young creators. The new line encourages children to confidently apply their imagination and bring their biggest ideas to life with simple materials and without the mess of glue."Kids are natural creators, builders and problem-solvers," said Amanda Dauphiniais, vice

    7/14/26 7:46:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group President Bauer Wendy A exercised 7,952 shares at a strike of $159.96 and covered exercise/tax liability with 3,558 shares, increasing direct ownership by 94% to 9,086 units (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    7/2/26 9:13:09 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Director Rumsey Jennifer was granted 1,196 shares (SEC Form 4)

    4 - 3M CO (0000066740) (Issuer)

    6/9/26 4:07:08 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Rumsey Jennifer

    3 - 3M CO (0000066740) (Issuer)

    6/9/26 4:04:16 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    SEC Filings

    View All

    SEC Form 10-Q filed by 3M Company

    10-Q - 3M CO (0000066740) (Filer)

    7/21/26 12:08:01 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - 3M CO (0000066740) (Filer)

    7/21/26 6:34:07 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - 3M CO (0000066740) (Filer)

    6/8/26 11:02:11 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    3M upgraded by Analyst with a new price target

    Analyst upgraded 3M from Neutral to Overweight and set a new price target of $180.00

    7/17/26 8:16:24 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Goldman resumed coverage on 3M with a new price target

    Goldman resumed coverage of 3M with a rating of Buy and set a new price target of $190.00

    6/15/26 8:11:43 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Bernstein initiated coverage on 3M with a new price target

    Bernstein initiated coverage of 3M with a rating of Underperform and set a new price target of $131.00

    6/10/26 8:40:45 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/13/24 4:56:03 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/23 10:54:46 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    SC 13G/A - 3M CO (0000066740) (Subject)

    2/9/22 3:15:56 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Leadership Updates

    Live Leadership Updates

    View All

    3M Announces New Board Appointment

    Jennifer Rumsey, Chair and Chief Executive Officer of Cummins Inc., elected to the Board of DirectorsBrings deep experience leading a global industrial technology companyST. PAUL, Minn., June 8, 2026 /PRNewswire/ -- 3M (NYSE:MMM) announced today the election of Jennifer W. Rumsey to 3M's Board of Directors, effective June 5, 2026. Ms. Rumsey also has been appointed as a member of the Science, Technology and Sustainability Committee of the Board."Jennifer is a highly regarded leader with deep experience driving growth across global industrial markets through innovation and technology," said William M. Brown, 3M's Chairman and Chief Executive Officer. "She will bring valuable perspective to ou

    6/8/26 11:00:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Annual Meeting Results

    ST. PAUL, Minn., May 12, 2026 /PRNewswire/ -- At today's Annual Meeting of Shareholders, 3M (NYSE:MMM) shareholders overwhelmingly supported each of the proposals recommended for approval by the company.Preliminary Shareholder Voting Results3M shareholders today voted on the following business items:1) Shareholders supported 10 directors for one-year terms:David P. Bozeman, President, Chief Executive Officer and Director, C.H. Robinson Worldwide, Inc.Thomas "Tony" K. Brown, retired Group Vice President, Global Purchasing, Ford Motor CompanyWilliam M. "Bill" Brown, Chairman of the Board and Chief Executive Officer, 3M CompanyAudrey Choi, retired Chief Sustainability Officer and Management Com

    5/12/26 4:46:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M appoints Meagan Linn as Senior Vice President, Government Affairs

    ST. PAUL, Minn., Feb. 16, 2026 /PRNewswire/ -- 3M today announced the appointment of Meagan Linn as Senior Vice President, Government Affairs. In this role, Linn will oversee the company's engagement with the executive branch, policymakers, regulatory agencies, and industry associations, globally to advance public policy dialogue. She will also be responsible for developing business growth through government contracts. Linn brings 20 years of experience in public policy, with 12 years at Northrop Grumman Corporation, most recently as government policy lead and Chief of Staff, an

    2/16/26 10:00:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $MMM
    Financials

    Live finance-specific insights

    View All

    3M Reports Second-Quarter 2026 Results; Increases Full-Year Guidance

    Q2 GAAP sales of $6.5 billion, up 2.4%; operating margin of 15.1%, down 290 bps; EPS of $1.78, up 33%, all YoY Adjusted sales of $6.5 billion with organic growth of 5.4% YoYAdjusted operating margin of 24.9%, up 40 bps YoYAdjusted EPS of $2.40, up 11% YoYQ2 operating cash flow of $1.0 billion with adjusted free cash flow of $1.3 billion2026 adjusted EPS guidance increased from $8.50 - $8.70 to $8.80 - $8.95ST. PAUL, Minn., July 21, 2026 /PRNewswire/ -- 3M (NYSE:MMM) today reported second-quarter results."We delivered a strong second quarter, exceeding expectations with mid-single-digit sales growth, robust operating margins of about 25%, and double-digit EPS growth, reflecting the progress w

    7/21/26 6:30:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Announces Upcoming Investor Event

    ST. PAUL, Minn., July 7, 2026 /PRNewswire/ -- 3M (NYSE: MMM) today announced the following investor event:Second-quarter 2026 earnings conference call on Tuesday, July 21, 2026, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com.About 3M3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footprint, and operational excellence. Discover how 3M is shaping the future at 3M

    7/7/26 10:15:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    3M Board Declares Quarterly Dividend

    ST. PAUL, Minn., May 12, 2026 /PRNewswire/ -- The 3M Company Board of Directors (NYSE:MMM) today declared a dividend on the company's common stock of $0.78 per share for the second quarter of 2026. The dividend is payable June 12, 2026, to shareholders of record at the close of business on May 22, 2026.3M has paid dividends to its shareholders without interruption for more than 100 years.About 3M3M (NYSE:MMM) is focused on transforming industries around the world by applying science and creating innovative, customer-focused solutions. Our multi-disciplinary team is working to solve tough customer problems by leveraging diverse technology platforms, differentiated capabilities, global footpri

    5/12/26 5:01:00 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care